Promoting Resilience in Teens With ASD
Status unconfirmed · Not applicable
Conditions studied: Autism Spectrum Disorder
In brief
Interventions for Autism Spectrum Disorder (ASD) are almost uniformly costly and time-intensive, blunting dissemination of intervention and stymying opportunities to make scalable impact. This study offers the first pilot randomized controlled trial (RCT) of whether a single session intervention, shown to reduce internalizing problems in typically-developing youth, may improve core and co-occuring symptoms of ASD.
Key facts
- Study ID
- NCT04208425
- Run by
- Stony Brook University
- People needed
- 40
- Starts
- 2019-01-07
- Expected to finish
- 2022-03-01
- Last updated by the study team
- 2020-03-18
Who can join
Age: 11 and older, up to 16. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Youth between the ages of 11-16 (inclusive) at the time of study participation;
- Youth with one parent or legal guardian willing to participate in the study (i.e. to be present for the lab visit and to complete questionnaires throughout the study period);
- Youth speaks English well enough to complete online or virtual based intervention activities;
- Youth with IQ ≥ 70;
- Parent or legal guardian speaks English well enough to complete online questionnaires;
- Youth with SCQ >10;
- Youth who meet criteria for autism or ASD on the ADOS-2.
You may not qualify if…
- Failure to meet the above inclusion criteria;
- Intellectual disability (IQ<70), as this may undermine comprehension of intervention materials;
- Adolescent is non-English speaking;
- The presence of a known developmental disability aside from ASD that would interfere with study participation;
- The presence of a significant medical disability or disorder that would interfere with study participation.
Where it is running
- Stony Brook University — Stony Brook, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.